BioStem Technologies, Inc.
BSEM
$4.02
$0.112.68%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.65% | 106.60% | 553.70% | 252.72% | 216.48% |
| Total Depreciation and Amortization | 9.48% | -8.34% | 3.05% | -10.92% | 11.37% |
| Total Amortization of Deferred Charges | -83.15% | -73.90% | -12.80% | -2.81% | 641.45% |
| Total Other Non-Cash Items | -22.71% | -31.99% | -48.56% | -25.98% | -14.02% |
| Change in Net Operating Assets | 45.91% | 128.88% | 65.30% | -624.55% | -3,701.58% |
| Cash from Operations | -52.28% | 270.89% | 974.37% | 567.89% | 691.77% |
| Capital Expenditure | -887.03% | -126.85% | -674.39% | -180.44% | -97.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 53.52% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 209.17% | -1,290.48% | -1,287.08% | -- | -1,310.36% |
| Cash from Investing | -7.73% | -586.58% | -2,847.22% | -634.81% | -450.52% |
| Total Debt Issued | -- | -- | -- | -- | -97.37% |
| Total Debt Repaid | 2.63% | 18.61% | 62.39% | 11.41% | -34.39% |
| Issuance of Common Stock | -97.89% | -94.09% | -94.49% | -85.29% | 414.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -198.27% | -169.87% | -111.64% | -112.57% | -38.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.18% | 156.91% | 3,501.82% | 2,797.84% | 1,656.85% |